Differential Contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in Vivo Renal Uptake of Uremic Toxins in Rats

[1]  M. Otagiri,et al.  Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats , 2003, Biopharmaceutics & drug disposition.

[2]  M. Satoh,et al.  Uremic Toxins Overload Accelerates Renal Damage in a Rat Model of Chronic Renal Failure , 2003, Nephron Experimental Nephrology.

[3]  Yuichi Sugiyama,et al.  Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat , 2003, Journal of Pharmacology and Experimental Therapeutics.

[4]  F. Russel,et al.  Modulatory effects of hormones, drugs, and toxic events on renal organic anion transport. , 2003, Biochemical pharmacology.

[5]  H. Yamato,et al.  Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. , 2003, Kidney international.

[6]  Xiao‐ping Yang,et al.  Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. , 2003, American journal of physiology. Renal physiology.

[7]  H. Takanaga,et al.  Rat Organic Anion Transporter 3 (rOAT3) is Responsible for Brain-to-Blood Efflux of Homovanillic Acid at the Abluminal Membrane of Brain Capillary Endothelial Cells , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  M. Takano,et al.  Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. , 2002, The Journal of pharmacology and experimental therapeutics.

[9]  H. Takanaga,et al.  Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. , 2002, Kidney international.

[10]  H. Kusuhara,et al.  Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. , 2002, Molecular pharmacology.

[11]  H. Kusuhara,et al.  Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. , 2002, The Journal of pharmacology and experimental therapeutics.

[12]  Yuichi Sugiyama,et al.  Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Z. Massy,et al.  Uremic Toxicity: Present State of the Art , 2001, The International journal of artificial organs.

[14]  T. Abe,et al.  Characterization of the Efflux Transport of 17β-Estradiol-d-17β-glucuronide from the Brain across the Blood-Brain Barrier , 2001 .

[15]  H. Seo,et al.  An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  M. Otagiri,et al.  Interaction Between Two Dicarboxylate Endogenous Substances, Bilirubin and an Uremic Toxin, 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid, on Human Serum Albumin , 1999, Pharmaceutical Research.

[17]  T. Koizumi,et al.  Applecation of a Non-linear Dispersion Model to Analysis of the Renal Handling of p-Aminohippurate in Isolated Perfused Rat Kidney , 1999 .

[18]  H. Kusuhara,et al.  Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.

[19]  G Somerville,et al.  The present state-of-the-art , 1998 .

[20]  T. Miyazaki,et al.  The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. , 1997, Kidney international. Supplement.

[21]  H. Seo,et al.  Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. , 1997, Kidney international. Supplement.

[22]  M. Otagiri,et al.  Characterization of binding site of uremic toxins on human serum albumin. , 1995, Biological & pharmaceutical bulletin.

[23]  T. Niwa,et al.  Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. , 1994, The Journal of laboratory and clinical medicine.

[24]  T. Terasaki,et al.  In vivo evidence for carrier-mediated uptake of beta-lactam antibiotics through organic anion transport systems in rat kidney and liver. , 1990, The Journal of pharmacology and experimental therapeutics.

[25]  W. Pardridge,et al.  Selective availability of protein bound estrogen and estrogen conjugates to the rat kidney , 1987, Journal of endocrinological investigation.

[26]  W. Oldendorf,et al.  Carotid Artery Injection Technique: Bounds for Bolus Mixing by Plasma and by Brain , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  W. Pardridge,et al.  Kinetics of Neutral Amino Acid Transport Through the Blood‐Brain Barrier of the Newborn Rabbit , 1982, Journal of neurochemistry.

[28]  H. Breuer,et al.  Disposition of oestrone sulphate by the isolated perfused rat kidney. , 1977, Biochemical Society transactions.

[29]  H. Kusuhara,et al.  Characterization of uremic toxin transport by organic anion transporters in the kidney. , 2004, Kidney international.

[30]  G. Burckhardt,et al.  Transport of organic anions across the basolateral membrane of proximal tubule cells. , 2003, Reviews of physiology, biochemistry and pharmacology.

[31]  T. Abe,et al.  Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier. , 2001, The Journal of pharmacology and experimental therapeutics.

[32]  T Nakagawa,et al.  A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.